Agios Pharmaceuticals

Agios Pharmaceuticals

A public american pharmaceutical company

No article has been written about this topic yet.
Paste a URL about this topic to auto-extract knowledge.
Visit our Writing Guide for help on how to write about a topic,
and check out an example of a well filled out topic page.

No article has been written about this topic yet.
Be the first one to add some text.

Loading AI-assisted edit mode...

Timeline

Funding rounds

Funding round
Funding type
Funding round amount (USD)
Funding round date
Investment
Agios Pharmaceuticals Series C round
Series C round
78,000,000
November 17, 2011
Celgene
Agios Pharmaceuticals funding round, April 2010
8,823,937
April 26, 2010
Agios Pharmaceuticals funding round, December 2009
December 23, 2009
3 Results
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

Abhishek Jha

Employee

Amit Patel

Investor

Christopher Dovletoglou

Employee

Darrin Miles

Employee

Fay Xing

Investor

Fran Lacombe

Employee

Grant K. Walkup, PhD

Employee

Jay Vaithilingam

Employee

Jenny Che

Employee

Kate McSheffrey

Employee

Laura J. Palermino

Employee

Osman Emara

Employee

Patrizio Renzetti

Employee

Thomas Roddy

Employee

Tien Dao

Employee

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
June 9, 2020
BioSpace
Thermo Fisher Scientific to Co-develop a Global Companion Diagnostic for Low-grade Glioma with Agios Pharmaceuticals - read this article along with other careers information, tips and advice on BioSpace
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.